Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
A pre-combined vial simplifies protocols that would otherwise require reconstituting and dosing two compounds separately
Additionally, certain medical conditions, including cystic fibrosis and HIV/AIDS, can also lead to reduced glutathione levels
Not a compound, food, or cosmetic
Dymatize L-Carnitine is a great supplement that brings about effective weight loss when combined with an intensive exercise regime
When supplemented, GBB dramatically increases both plasma and urinary carnitine levels -- research shows it can boost carnitine excretion up to 40-fold compared to baseline
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
US$ 26.73
US$ 23.32
US$ 24.25
